Literature DB >> 2809414

Inhibitory effect of SV-IV, a major protein secreted from the rat seminal vesicle epithelium, on phagocytosis and chemotaxis of human polymorphonuclear leukocytes.

S Metafora1, R Porta, G Ravagnan, G Peluso, M A Tufano, L De Martino, R Ianniello, F Galdiero.   

Abstract

The effect of SV-IV, one of the major proteins secreted from the rat seminal vesicle epithelium, on phagocytosis and chemotaxis of human polymorphonuclear leukocytes (PMNs) has been studied. Various cytological, biochemical, metabolic, and physical correlates of both biological activities have been found to be markedly reduced by the presence in the medium of micromolar concentrations of protein SV-IV. Moreover, the Scatchard analysis of the labeled SV-IV binding to PMN cell surface has demonstrated that such binding is specific. The binding sites contain only saturable components, completely displaceable by unlabeled SV-IV. The number of the specific sites has been calculated to be 87,000/cell, with a Kd of 1.72 X 10(-7) M. The molecular mechanism of the inhibitory effect is discussed along with the possible biological and clinical implications of the experimental findings.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809414     DOI: 10.1002/jlb.46.5.409

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  3 in total

1.  The N-terminal 1-16 peptide derived in vivo from protein seminal vesicle protein IV modulates alpha-thrombin activity: potential clinical implications.

Authors:  Marilena Lepretti; Susan Costantini; Gaetano Ammirato; Gaia Giuberti; Michele Caraglia; Angelo M Facchiano; Salvatore Metafora; Paola Stiuso
Journal:  Exp Mol Med       Date:  2008-10-31       Impact factor: 8.718

2.  Effect of protein SV-IV on experimental Salmonella enterica serovar Typhimurium infection in mice.

Authors:  Caterina Romano-Carratelli; Concetta Bentivoglio; Immacolata Nuzzo; Nunzia Benedetto; Elisabetta Buommino; Anna Cozzolino; Maria Cartenì; Francesco Morelli; Maria Rosaria Costanza; Biancamaria Metafora; Vittoria Metafora; Salvatore Metafora
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

3.  SV-IV Peptide1-16 reduces coagulant power in normal Factor V and Factor V Leiden.

Authors:  Biagio Di Micco; Marilena Lepretti; Lidia Rota; Ilaria Quaglia; Paola Ferrazzi; Gianluca Di Micco; Pierpaolo Di Micco
Journal:  J Transl Med       Date:  2007-12-21       Impact factor: 5.531

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.